This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (358) JMIR Theme Issue: COVID-19 Special Issue (1661) Outbreak and Pandemic Preparedness and Management (1252) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1194) Infectious Diseases (non-STD/STI) (1111) Medication Adherence (45) Doctor-Patient Communication on Cancer, Prevention, and Screening (34) Personal Health Records, Patient-Accessible Electronic Health Records, Patient Portals (378) Patient-Reported Outcome Measures (PROMs) (205)

Published on in Vol 10, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25271, first published .
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

Authors of this article:

Fabio Efficace 1 Author Orcid Image ;   Massimo Breccia 2 Author Orcid Image ;   Paola Fazi 1 Author Orcid Image ;   Francesco Cottone 1 Author Orcid Image ;   Bernhard Holzner 3, 4 Author Orcid Image ;   Marco Vignetti 1 Author Orcid Image
Article Authors Cited by Tweetations (6) Metrics
Fabio Efficace 1, PhD;  Massimo Breccia 2, MD;  Paola Fazi 1, MD;  Francesco Cottone 1, PhD;  Bernhard Holzner 3, 4, PhD;  Marco Vignetti 1, MD

1 Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA) , Rome , IT

2 Department of Precision and Translational Medicine, Sapienza University , Rome , IT

3 University Hospital of Psychiatry II, Medical University of Innsbruck , Innsbruck , AT

4 Evaluation Software Development Ltd , Innsbruck , AT

Corresponding Author:

  • Fabio Efficace, PhD
  • Data Center and Health Outcomes Research Unit
  • Italian Group for Adult Haematologic Diseases (GIMEMA)
  • via Casilina 5
  • Rome
  • IT
  • Phone: 39 06441639831
  • Email: f.efficace@gimema.it